Drug Target Review2025-12-29T10:00:15
A new study published has demonstrated that reducing background brain activity can sharpen attention, identifying the Homer1 gene as key to developing new targeted treatments for ADHD and related disorders.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-31T06:00:00Z
Contributor Dr Davinder Ramsingh, Drug Target Review
2024-01-24T12:52:38
Sponsored by BellBrook Labs
2025-05-08T09:00:00
Contributor Ning Ren
2025-09-24T14:00:00
Sponsored by Eurofins Discovery
2023-12-11T10:49:07
Sponsored by Leica Microsystems
2023-05-30T13:51:56
Sponsored by BPS Bioscience
Site powered by Webvision Cloud